The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients

Ma, KF; Hong, BA; Zhou, JC; Gong, YQ; Wang, JY; Liu, SJ; Peng, X; Zhou, BW; Zhang, JF; Xie, HB; Zhang, KN; Li, L; Cai, DS; Wang, ZX; Cai, L; Gong, K

Cai, L; Gong, K (reprint author), Peking Univ, Dept Urol, Hosp 1, Beijing, Peoples R China.; Cai, L; Gong, K (reprint author), Peking Univ, Hereditary Kidney Canc Res Ctr, Hosp 1, Beijing, Peoples R China.; Cai, L; Gong, K (reprint author), Peking Univ, I

FRONTIERS IN ONCOLOGY, 2019; 9 ():

Abstract

Background: Von Hippel-Lindau (VHL) disease is an autosomal-dominant hereditary cancer syndrome. Currently, studies on tyrosine kinase inhibitor (TKI)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索